Stay updated on Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page

  1. Check
    8 days ago
    No Change Detected
  2. Check
    15 days ago
    Change Detected
    Summary
    A new revision 'v3.3.3' was added, and the 'HHS Vulnerability Disclosure' link and the previous revision 'v3.3.2' were removed.
    Difference
    0.1%
    Check dated 2025-12-23T01:36:29.000Z thumbnail image
  3. Check
    22 days ago
    No Change Detected
  4. Check
    29 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page footer shows a revision update from v3.3.1 to v3.3.2, which appears to be an internal versioning change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T11:48:05.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Added clarification that publications in the Study Results section are provided voluntarily by the study submitter and that some entries are auto-filled from PubMed. Updated the revision label to v3.3.1 and adjusted the publication wording accordingly; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-24T12:11:46.000Z thumbnail image
  7. Check
    51 days ago
    Change Detected
    Summary
    The page no longer displays the NIH/CC government funding and operating status notice, which was a site-wide message. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T06:20:36.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    Minor layout adjustments and copy edits were detected on the Study Details page; no core study content, eligibility criteria, endpoints, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T00:58:21.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Updates present: a funding/operating status notice and a version bump to v3.2.0; removal of a specific resource entry and older revision tag (v3.1.0).
    Difference
    3%
    Check dated 2025-10-05T08:31:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Standard Therapy in Esophageal Cancer Clinical Trial page.